Glaukos Announces Participation in Wells Fargo Healthcare Conference
Business Wire•19/08/2026•07:00 ET
0
Whiz Insights
Glaukos Announces Participation in Wells Fargo Healthcare Conference
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 3:00 p.m. ET in Boston, MA.
Get started
Create a free account to read the full story.